Keyphrases
Genetic Polymorphism
100%
Left Ventricular Assist Device
100%
Heart Failure Patients
66%
HeartMate II
50%
HeartMate 3
50%
HeartWare
50%
Mechanical Circulatory Support
50%
Direct Oral Anticoagulants
50%
Carboxylesterase 1 (CES1)
50%
Congestive Heart Failure
50%
Dabigatran
42%
Genotype Polymorphism
37%
Device Complications
33%
VKORC1
33%
Rs5918
29%
Thrombosis
29%
Non-valvular Atrial Fibrillation
28%
UGT1A6
25%
ITGB3
25%
SNP
25%
Rs9923231
20%
Metabolism
20%
Left Ventricular Assist Device Implantation
20%
Thromboelastography
16%
Antithrombotic Therapy
16%
ITGB3 Gene
16%
Bleeding
16%
Apixaban
14%
Rs1045642
14%
Rs2244613
14%
Individualized Dosing
12%
Coagulation System
12%
Healthy Controls
12%
Mortality Rate
12%
Physiologic
12%
Bleeding Complications
12%
High Risk
12%
Left Ventricular Assist Device Support
12%
Complication Risk
12%
Anticoagulant Therapy
12%
Hemostasis
12%
Warfarin
12%
Single nucleotide Polymorphism
12%
Shear Stress
12%
Aspirin
12%
Variability in Response
8%
Device Type
8%
Coagulation Index
8%
Platelet Function
8%
Coagulation State
8%
INIS
genetics
100%
patients
100%
devices
100%
heart failure
71%
carboxylesterases
50%
therapy
35%
genes
28%
genotype
28%
thrombosis
21%
shear
21%
information
14%
metabolism
14%
comparative evaluations
7%
quality of life
7%
reduction
7%
data
7%
management
7%
nucleotides
7%
mortality
7%
aspirin
7%
control
7%
anticoagulants
7%
risks
7%
Medicine and Dentistry
Genetic Polymorphism
100%
Assisted Circulation
50%
Left Ventricular Assist Device
50%
Heart Failure
25%
Thromboelastography
16%
Antithrombotic Therapy
16%
Bleeding
16%
Thrombosis
16%
Thrombocyte Function
8%
DNA Polymorphism
8%
Quality of Life
8%
Genotype
8%
Coagulopathy
8%
Heredity
8%